Table 1.
Baseline characteristics of the participants with and without albuminuria at the 6-year follow-up visit
| Characteristic | No micro- or macroalbuminuria at 6-year follow-up visit (n = 299) | Micro- or macroalbuminuria at 6-year follow-up (n = 25) |
|---|---|---|
| Age (years) | 37 ± 9 | 37 ± 9 |
| Duration of type 1 diabetes (years) | 23 ± 9 | 22 ± 7 |
| ACE inhibitor or ARB (%) | 24 | 67 |
| Systolic blood pressure (mmHg) | 115 ± 13 | 117 ± 9 |
| Diastolic blood pressure (mmHg) | 76 ± 8 | 79 ± 7 |
| BMI (kg/m2) | 26 ± 4 | 28 ± 5 |
| Waist circumference (cm) | 84 ± 12 | 91 ± 16 |
| HbA1c (%) | 7.7 ± 1.2 | 8.5 ± 1.4* |
| Pre-albuminuria (ACR < 30 mg/g) | 5.1 ± 1.7 | 8.5 ± 2.0** |
| Serum creatinine (mg/dl) | 1.1 ± 0.2 | 1.2 ± 0.2 |
| Cystatin C (mg/l) | 0.76 ± 0.1 | 0.8 ± 0.1 |
| Total cholesterol (mg/dl) | 170 ± 32 | 173 ± 32 |
| LDL cholesterol (mg/dl) | 97 ± 28 | 98 ± 25 |
| Triglycerides (mg/dl) | 75 ± 2 | 101 ± 2 * |
| HDL cholesterol (mg/dl) | 57 ± 17 | 51 ± 16 |
ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; BMI, body mass index; ACR, urinary albumin/creatinine ratio; LDL, low-density lipoprotein; HDL, high-density lipoprotein. Values above are presented as mean ± standard deviation or geometric mean (standard deviation). *P < 0.05, **P < 0.001.